HCW Biologics (HCWB) Competitors $4.50 +0.28 (+6.64%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$4.14 -0.36 (-8.00%) As of 05:30 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock HCWB vs. KALA, ALXO, ENLV, GBIO, TPST, DARE, SNYR, CARA, PASG, and CVKDShould you be buying HCW Biologics stock or one of its competitors? The main competitors of HCW Biologics include KALA BIO (KALA), ALX Oncology (ALXO), Enlivex Therapeutics (ENLV), Generation Bio (GBIO), Tempest Therapeutics (TPST), Dare Bioscience (DARE), Synergy CHC (SNYR), Cara Therapeutics (CARA), Passage Bio (PASG), and Cadrenal Therapeutics (CVKD). These companies are all part of the "pharmaceutical products" industry. HCW Biologics vs. Its Competitors KALA BIO ALX Oncology Enlivex Therapeutics Generation Bio Tempest Therapeutics Dare Bioscience Synergy CHC Cara Therapeutics Passage Bio Cadrenal Therapeutics KALA BIO (NASDAQ:KALA) and HCW Biologics (NASDAQ:HCWB) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and media sentiment. Do analysts recommend KALA or HCWB? KALA BIO currently has a consensus price target of $13.50, suggesting a potential upside of 192.21%. HCW Biologics has a consensus price target of $35.00, suggesting a potential upside of 677.78%. Given HCW Biologics' higher possible upside, analysts plainly believe HCW Biologics is more favorable than KALA BIO.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KALA BIO 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00HCW Biologics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is KALA or HCWB more profitable? KALA BIO has a net margin of 0.00% compared to HCW Biologics' net margin of -1,712.94%. KALA BIO's return on equity of -369.29% beat HCW Biologics' return on equity.Company Net Margins Return on Equity Return on Assets KALA BION/A -369.29% -64.99% HCW Biologics -1,712.94%-2,516.84%-90.09% Which has preferable earnings & valuation, KALA or HCWB? HCW Biologics has lower revenue, but higher earnings than KALA BIO. KALA BIO is trading at a lower price-to-earnings ratio than HCW Biologics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKALA BIO$3.89M7.66-$38.51M-$8.24-0.56HCW Biologics$2.57M2.52-$30.02M-$23.25-0.19 Do institutionals & insiders hold more shares of KALA or HCWB? 24.6% of KALA BIO shares are held by institutional investors. Comparatively, 3.0% of HCW Biologics shares are held by institutional investors. 8.3% of KALA BIO shares are held by insiders. Comparatively, 42.7% of HCW Biologics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media refer more to KALA or HCWB? In the previous week, KALA BIO had 2 more articles in the media than HCW Biologics. MarketBeat recorded 8 mentions for KALA BIO and 6 mentions for HCW Biologics. HCW Biologics' average media sentiment score of 0.48 beat KALA BIO's score of -0.28 indicating that HCW Biologics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KALA BIO 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral HCW Biologics 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, KALA or HCWB? KALA BIO has a beta of -1.98, indicating that its stock price is 298% less volatile than the S&P 500. Comparatively, HCW Biologics has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. SummaryKALA BIO beats HCW Biologics on 9 of the 15 factors compared between the two stocks. Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HCWB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCWB vs. The Competition Export to ExcelMetricHCW BiologicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.48M$2.82B$5.45B$8.90BDividend YieldN/A2.70%5.35%4.14%P/E Ratio-0.1921.1626.2419.67Price / Sales2.52279.07408.37112.14Price / CashN/A41.2925.7827.49Price / Book-0.747.197.885.41Net Income-$30.02M-$55.05M$3.16B$248.99M7 Day Performance-3.64%1.53%2.56%2.85%1 Month Performance-43.04%5.83%5.28%5.49%1 Year Performance-82.61%-0.74%31.75%16.97% HCW Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCWBHCW Biologics3.2889 of 5 stars$4.50+6.6%$35.00+677.8%-82.6%$6.48M$2.57M-0.1940High Trading VolumeKALAKALA BIO3.5123 of 5 stars$4.02-0.5%$13.50+235.8%-34.8%$26.07M$3.89M-0.4930News CoverageGap UpALXOALX Oncology2.951 of 5 stars$0.46-5.0%$3.30+617.9%-93.3%$25.84MN/A-0.1940Positive NewsENLVEnlivex Therapeutics3.2835 of 5 stars$1.16+6.4%$10.00+762.1%-15.5%$25.78MN/A-1.7670GBIOGeneration Bio3.4186 of 5 stars$0.36-5.3%$7.33+1,937.6%-89.3%$25.47M$24.56M-0.33150Gap UpTPSTTempest Therapeutics1.7795 of 5 stars$6.85+1.0%$30.00+338.0%-75.8%$24.97MN/A-0.3820DAREDare Bioscience2.4956 of 5 stars$2.56-9.2%$12.00+368.8%-41.2%$24.96M$10K-15.0630Positive NewsHigh Trading VolumeSNYRSynergy CHC3.6843 of 5 stars$2.57-3.0%$10.00+289.1%+1,418.8%$24.36M$34.83M0.0040Gap UpCARACara Therapeutics0.3218 of 5 starsN/AN/AN/A$24.33M$7.14M-0.2580Gap DownHigh Trading VolumePASGPassage Bio2.8549 of 5 stars$0.33-14.4%$7.50+2,140.1%-58.3%$24.30MN/A-0.33130Gap UpCVKDCadrenal Therapeutics3.6066 of 5 stars$11.44-7.4%$32.00+179.7%N/A$24.29MN/A-1.244Gap Down Related Companies and Tools Related Companies KALA BIO Competitors ALX Oncology Competitors Enlivex Therapeutics Competitors Generation Bio Competitors Tempest Therapeutics Competitors Dare Bioscience Competitors Synergy CHC Competitors Cara Therapeutics Competitors Passage Bio Competitors Cadrenal Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HCWB) was last updated on 6/30/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… And it's all thanks to President Trump. His ...InvestorPlace | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored“Trump’s 24-Hour Profit Windows” revealedTrading legend Larry Benedict has discovered a repeating surge of $240 billion (and more)... Flowing into a...Brownstone Research | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HCW Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
